HIGH POINT, N.C.--(BUSINESS WIRE)--TransTech Pharma, Inc. and High Point Pharmaceuticals, LLC. today announced that they have been awarded cash grants totaling $1.96 million under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) program.
